Ali A. Duarte Garcia, M.D.

Open

• Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (“APS ACTION”) International Clinical Database and Repository (APS ACTION) Rochester, Minn.

  The purpose of this study is to establish an international secure, web-based clinical database andrepository of aPL-positive patients that the natural course of at least 2000 patients can be followed over 10 years.

• The ANSWERS Study (ANtiphospholipid Syndrome- Working to Establish Real Solutions) Rochester, Minn.

  The purpose of this study is to better understand Antiphospholipid syndrome (APS) pathophysiology and to aid development of targeted therapeutics.